Mechanism of action of theophylline in bronchial asthma is:
**Core Concept**
Theophylline is a xanthine derivative used in the management of bronchial asthma. Its mechanism of action is multifaceted, but primarily involves the inhibition of a specific enzyme responsible for the breakdown of cyclic adenosine monophosphate (cAMP), a key intracellular signaling molecule.
**Why the Correct Answer is Right**
Theophylline exerts its bronchodilatory effects by inhibiting phosphodiesterase 4 (PDE4), an enzyme that catalyzes the hydrolysis of cAMP to AMP. This results in an increase in intracellular cAMP levels, leading to relaxation of bronchial smooth muscle and improved lung function. The inhibition of PDE4 also enhances the activity of other bronchodilatory pathways, such as beta2-adrenergic receptor stimulation.
**Why Each Wrong Option is Incorrect**
**Option B:** Beta2 agonism is the mechanism of action of beta2-agonist bronchodilators, such as salbutamol and terbutaline, which bind to beta2-adrenergic receptors to stimulate bronchodilation. Theophylline does not act through beta2 agonism.
**Option C:** Anticholinergic action is the mechanism of action of anticholinergic bronchodilators, such as ipratropium bromide, which block muscarinic receptors to inhibit bronchoconstriction. Theophylline does not act through anticholinergic mechanisms.
**Option D:** Inhibition of mucociliary clearance is not a known mechanism of action of theophylline. In fact, theophylline may help to improve mucociliary clearance by increasing cAMP levels in airway epithelial cells.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that theophylline has a narrow therapeutic index and can cause significant toxicity at high plasma concentrations. Regular monitoring of plasma theophylline levels is crucial to prevent toxicity and ensure optimal therapeutic effects.
**β Correct Answer: A. Phosphodiesterase 4 inhibition**